It can now be announced that AIIMS has marked a global first in pioneering stem cell medicine by the "injection method", placing the institute right at the top of the world's medicine map. This is very exciting news for diabetics and heart transplant patients. As part of a path breaking study. conducted from February 2003 to January 2005, 35 cardiac patients have been given stem cell treatment and have been monitored at 6, 12 and 18 month intervals.